Back

Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock

27 August 2023 (15:30 - 15:43)
Organised by: Logo
Congress Presentation Part of: Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment? Acute Pulmonary Embolism Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Sripal Bangalore

New York University Langone Medical Center, New York (United States of America)

3 More presentations in this session

Presentation thumbnail
New datasets impacting the status quo of the treatment of intermediate-high pulmonary embolism patients- FLASH, PEERLESS and PEERLESS II
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
How does FLAME data improve the management of high-risk pulmonary embolism patients?
Doctor C. Toma (Pittsburgh, US)
Slides Video
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 15:30 CET
You may be interested in
thumbnail
Congress Session
Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?
thumbnail
Congress Presentation
Intermediate-high risk pulmonary embolism: are we underestimating the danger?
thumbnail
Congress Presentation
Selecting the right patient at the right time: predictors and early decision-making in acute pulmonary embolism

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources